Reuters logo
BRIEF-U.S. PTO rules in Eli Lilly's favor on Alimta
October 5, 2017 / 8:33 PM / in 14 days

BRIEF-U.S. PTO rules in Eli Lilly's favor on Alimta

Oct 5 (Reuters) - Eli Lilly And Co

* Patent trial and appeal board of U.S. PTO ruled in company’s favor regarding patentability of vitamin regimen for Alimta

* In IPR proceedings initiated by Neptune Generics LLC and Sandoz, U.S. PTO found that claims of vitamin regimen patent are valid​

* If patent is ultimately upheld through all remaining challenges, Alimta would maintain U.S. exclusivity until May 2022​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below